POSTDOCTORAL RESEARCHER-Health Data Science and Biostatistics Department-Xu Lab

POSTDOCTORAL RESEARCHER Dr. Lin Xu has developed multiple deep learning models and statistical algorithms to identify novel disease genes and therapeutic targets [e.g., Huang et al. Nature (2020), Lu et al. Nature Machine Intelligence (2022), Chai et al. Nature Medicine (2022), Takahiko et al. Science Translational Medicine (2022) (Cover Story), Shi et al. Cancer Cell (2022), Lebek et al. Science (2023), Xu et al. Nature Communications (2023), Zhu et al. Cancer Cell (2023), Zhang et al. Journal of Clinical Investigation (2023), He et al. Nature Communications (2023), Yu et al. Nature Communications (2023), Santos et al. Nature Communications (2023), Li et al. Nature Communications (2023), Wei et al. Cell (2023), Hernandez et al. PNAS (2024), Hu L et al. Mol Cell (2024), Eglenen-Polat et al. Nature Communications (2024), Lin CC et al. Nature Communications (2024), Xu L. et al. Nature Communications (2024), Venkateswaran N. et al. Nature Communications (2024), Chen S. et al. Nature Communications (2025), Liao C, Nature Communications (2025), Yang X. et al. Nature Immunology (2025), Lu ZY. et al. Nature Communications (2025), Zhou Y. et al. Nature Communications (2025), Adachi Y et al. J Clin Invest. (2025), Napolitano F, et al. J Clin Invest. (2025), Bann et al. Circulation (2025), Ding et al. Circulation (2025), Caravia XM, et al. Proc. Natl. Acad. Sci. (2025), Guan P, et al. Proc. Natl. Acad. Sci. (2025), Engreitz JM, et al. Nature (2025), Li H et al., Science (2026)]. Since 2022, his lab’s research has been published in a series of high-impact journals, including Nature, Science, Cell, Nature Medicine, Cancer Cell, eLife, PNAS, Nature Machine Intelligence, Nature Immunology, Nature Metabolism, Nature Communications, Science Translational Medicine, Science Advances, Molecular Cell, Genes & Development, Cell Reports, Journal of Clinical Investigation, Circulation, Circulation Research, and Developmental Cell.

Building on these publications in bioinformatics and AI fields, the Xu Lab has received support from multiple funding sources, including the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), National Human Genome Research Institute (NHGRI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Cancer Prevention and Research Institute of Texas (CPRIT), U.S. Department of Defense (DoD), Hyundai Foundation, Children’s Cancer Fund, Sam Day Foundation, Rally Foundation, and Andrew McDonough B Foundation. Therefore, these new openings will be supported on a multi-year basis.

1) Ability to lead first-author manuscripts using large-scale single-cell or spatial omics data from patients already available in the Xu lab.

2) Experience with NGS data analysis and development of customized sequencing-analysis pipelines is strongly preferred.

3) Experience with Linux environments and command-line tools is required.

4) Doctoral degree in bioinformatics, genetics/genomics, statistics, biostatistics, computer science, systems biology, or a related field.

5) Excellent spoken and written English communication skills.

Interested individuals should send a CV, statement of interests, and a list of three references to:

Lin Xu, Ph.D.

Lin.xu@utsouthwestern.edu

UT Southwestern Medical Center is committed to an educational and working environment that provides equal opportunity to all members of the University community.  As an equal opportunity employer, UT Southwestern prohibits unlawful discrimination, including discrimination on the basis of race, color, religion, national origin, sex, sexual orientation, gender identity, gender expression, age, disability, genetic information, citizenship status, or veteran status.

This position is security-sensitive and subject to Texas Education Code 51.215, which authorizes UT Southwestern to obtain criminal history record information.

Appointment rank will be commensurate with academic accomplishment and experience. Consideration may be given to applicants seeking less than a full-time schedule.

To learn more about the benefits UT Southwestern offers, visit https://www.utsouthwestern.edu/employees/hr-resources/